Prospective analysis of patient‐reported outcomes and physician‐reported outcomes with gynecologic cancer chemotherapy

Feasibility study on collecting patient‐reported outcomes from breast cancer patients using the LINE‐ePRO system

(2022) Tetsu Hayashida et al.   CANCER SCIENCE

Defining a Standard Set of Patient-Reported Outcomes for Patients With Advanced Ovarian Cancer

(2022) Vicente Escudero-Vilaplana et al.   Frontiers in Oncology

Effect of Electronic Symptom Monitoring on Patient-Reported Outcomes Among Patients With Metastatic Cancer

(2022) Ethan Basch et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Underreporting of symptomatic adverse events in phase I clinical trials

(2021) Zachary W Veitch et al.   JNCI-Journal of the National Cancer Institute

Composite grading algorithm for the National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

(2020) Ethan Basch et al.   Clinical Trials

European society of neurogastroenterology and motility guidelines on functional constipation in adults

(2019) Jordi Serra et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Diagnosis, assessment and management of constipation in advanced cancer: ESMO Clinical Practice Guidelines†

(2018) P J Larkin et al.   ANNALS OF ONCOLOGY

Electronic Systems for Patients to Report and Manage Side Effects of Cancer Treatment: Systematic Review

(2018) Lorraine Warrington et al.   JOURNAL OF MEDICAL INTERNET RESEARCH

Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment

(2017) Ethan Basch et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Patient-Reported Outcomes — Harnessing Patients’ Voices to Improve Clinical Care

(2017) Ethan Basch   NEW ENGLAND JOURNAL OF MEDICINE

Making Patients and Doctors Happier — The Potential of Patient-Reported Outcomes

(2017) Lisa S. Rotenstein et al.   NEW ENGLAND JOURNAL OF MEDICINE

Patient-Reported Outcome Results from the Open-Label Randomized Phase III SELECT BC Trial Evaluating First-Line S-1 Therapy for Metastatic Breast Cancer

(2017) Takuya Kawahara et al.   ONCOLOGY

Electronic versus paper-pencil methods for assessing chemotherapy-induced peripheral neuropathy

(2017) Robert Knoerl et al.   SUPPORTIVE CARE IN CANCER

Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update Summary

(2017) Paul J. Hesketh et al.   Journal of Oncology Practice

Mode equivalence and acceptability of tablet computer-, interactive voice response system-, and paper-based administration of the U.S. National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

(2016) Antonia V. Bennett et al.   Health and Quality of Life Outcomes

Taxanes versus S-1 as the first-line chemotherapy for metastatic breast cancer (SELECT BC): an open-label, non-inferiority, randomised phase 3 trial

(2016) Tsutomu Takashima et al.   LANCET ONCOLOGY

Design, implementation and reporting strategies to reduce the instance and impact of missing patient-reported outcome (PRO) data: a systematic review

(2016) Rebecca Mercieca-Bebber et al.   BMJ Open

Validity and Reliability of the US National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

(2015) Amylou C. Dueck et al.   JAMA Oncology

Electronic patient-reported outcome systems in oncology clinical practice

(2012) Antonia V. Bennett et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Recommendations for Incorporating Patient-Reported Outcomes Into Clinical Comparative Effectiveness Research in Adult Oncology

(2012) Ethan Basch et al.   JOURNAL OF CLINICAL ONCOLOGY

The Missing Voice of Patients in Drug-Safety Reporting

(2010) Ethan Basch   NEW ENGLAND JOURNAL OF MEDICINE

Feasibility and validity of the Patient Neurotoxicity Questionnaire during taxane chemotherapy in a phase III randomized trial in patients with breast cancer: N-SAS BC 02

(2009) Kojiro Shimozuma et al.   SUPPORTIVE CARE IN CANCER